NASDAQ:AVCO

Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference

Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...

2019-06-13 20:00 9550

Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization

This milestone marks a pivotal point in Avalon's pipeline, now allowing the company to enter its next phase of commercializing clinical-grade exosome products FREEHOLD, New Jersey, June 10, 2019 /PRNewswire/ -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based techn...

2019-06-10 20:00 7222

Week's Top Stories